Seeing Machines shares steer higher as it wins contract with German car manufacturer
A look at some of the biggest risers and fallers in London today
Company
EMV Capital
LON:NSCI
EMV Capital plc is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies. With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future, the group invests in, manages, and strengthens early stage IP-rich companies.
424 stories · page 4 of 5
NetScientific portfolio company to give poster presentations at key US healthcare gathering
ProAxsis will give two poster presentations providing further data on its ProteaseTag technology
Archive
FTSE 100 closes in red as pound strengthens; BoE in focus
Around 4pm, the UK blue chip index fell 14 points to 7,490 as the Bank of England's interest rate decision looms
Archive
Proactive news snapshot: Kibo Mining, Symphony Environmental Technologies, ReNeuron …
A glance at some of the day's highlights from the Proactive Investors newswire
Netscienfic up as portfolio company ProAxsis enrols top US hospital to validate respiratory disease tag
ProAxsis will work with the NJH on validation of its ProteaseTag point-of-care technology
FTSE 100 ends the week on a firm note
The blue-chip index finished the day above the 7,500 level
Archive
Proactive news snapshot: Rose Petroleum, Ortac Resources, SDX Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
SSE rallies despite HSBC trimming its price target
SSE may have rallied, but Centrica remained down in the dumps, after HSBC trimmed its price target for the British Gas owner to 190p from 202p.
NetScientific's Glycotest subsidiary granted Japanese patent
The patent protects fucosylated kininogen - a key biomarker in the Glycotest's lead HCC Panel test for early-stage liver cancer.
FTSE 100 closes firmly in positive territory as sterling slides
The FTSE 100 rose to within a couple of points of 7,500 after US markets opened higher
Archive
Proactive news snapshot: Hurricane Energy, AFC Energy, Canadian Overseas Petroleum …
A glance at some of the day's highlights from the Proactive Investors newswire
Greencore Group dives following product recall in the US
The US Food and Drug Administration's sampling found some Listeria monocytogenes in Greencore's sandwiches
NetScientific portfolio company Wanda gets US patent to further protect its core technology
San Francisco-based Wanda is dedicated to advancing the effectiveness and efficiency of medicine by using machine learning in place of conventional technologies
FTSE 100 closes firmly higher as weak pound gives it a boost
FTSE 100 closed over 66 points higher at 7,438 with budget carrier easyJet the top flyer
Archive
Proactive news snapshot: Green Dragon Gas, Ergomed, IXICO …
A glance at some of the day's highlights from the Proactive Investors newswire
Petra Diamonds' shares sparkle after Tanzania lifts export ban
The government of Tanzania has given Petra the go-ahead to resume diamond exports and sales from the Williamson mine.
NetScientific positioned for continued commercial momentum
The most important number in the results statement was the cash balance of £11.3mln as at the end of June
FTSE 100 closes up but optimism not "particularly high"
FTSE 100 ended in positive territory, having been lower earlier,..
Investments and investor services
Eyes on TUI as it reveals first half results on Thursday
TUI already tipped off the market that it enjoyed a strong second quarter performance.
Archive
Proactive news snapshot: Newmark Security, Abzena, accesso Technology …
A glance at some of the day's highlights from the Proactive Investors newswire
Metminco surges as its gets go-ahead for underground development at Miraflores
Some of the main news-driven risers and fallers at 3.45pm...
NetScientific says portfolio company ProAxsis has appointed Diagenics as distributor for its ProteaseTag® product in Great Britain and Ireland
The transatlantic healthcare IP commercialisation group said the appointment is expected to accelerate the commercial uptake of ProAxsis' technology, increasing near-term sales potential
Investments and investor services
FTSE 100 closes firmly lower as pound strengthens; Next surges
Sterling surged past US$1.33 shortly after the Bank of England voted in favour of keeping interest rates at 0.25%, with analysts describing the move as a 'hawkish hold'
Archive
Proactive news snapshot: ANGLE, Jersey Oil & Gas, Mosman Oil And Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
NetScientific portfolio company, ProAxsis signs partnership agreement with large US biotech firm to develop activity-based immunoassays
The AIM-listed transatlantic healthcare IP commercialisation group said ProAsis’s unnamed partner is a large biotechnology company, headquartered in the US with a focus on developing new therapeutic options for patients with rare diseases
Archive
Proactive news snapshot: 88 Energy, Sound Energy, Sunrise Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Faron Pharma shares lifted by Traumakine progress, Highland Gold falls on first half earnings dip
A look at some of the top risers and fallers in London today
NetScientific says portfolio company, ProAxsis now able to initiate sales of its NEATstik® product throughout Europe
NEATstik® is a novel point-of-care test for measuring active neutrophil elastase, a serine proteinase which destroys bacteria and host tissue during inflation
NetScientific's portfolio company ProAxsis secures grant for ProteaseTag technology
NetScientific said the award will enable ProAxsis to generate further clinical data
Archive
Proactive end of day news round-up: UK Oil & Gas, 88 Energy, Aminex ...
A glance at some of the stories on the Proactive newswire today
Netscientific portfolio company in cancer clinical trial with US drugs giant Merck & Co unit
The collaboration will see PDS Biotechnology Corp and a subsidiary of Merck & Co Inc embark on a new clinical trial collaboration for metastatic head and neck cancer
Archive
Proactive news snapshot: Sound Energy, Blur, Ortac Resources...
A glance at some of the stories on the Proactive newswire today
LightwaveRF shares power up on Apple certification news
Proactive is monitoring all the movers and shakers on the day
Netscientific granted exclusive patent in Europe for liver cancer diagnostic
"We are very pleased to announce international strengthening of the IP landscape controlled by Glycotest in the field of liver diagnostics,” said Martelet. “The patents provide the foundation for future value enhancement and represent a cri
FTSE 100 enjoys late surge to ensure it finishes the week ahead
The top-share index finished up on the day and therefore up on the week also
Archive
Proactive end of day round-up: Michelmersh Brick, Scancell, VIctoria Oil & Gas...
A glance at some of the small cap stories on the Proactive newswire today
LPA Group shares fall as it warns on political uncertainty
A look at the biggest risers and fallers among the UK's small caps today
NetScientific’s Glycotest to complete recent fundraising later this year
US-based Glycotest had initially hoped to have the funding round completed by the end of June
Archive
Proactive news round-up: Sound Energy, Europa Oil & Gas, Galileo Resources ...
A glance at some of the headlines on the Proactive newswire today...
Archive
Proactive news round-up: Tertiary Minerals, Vast Resources, Netscientific ...
A round-up of small cap stories on the London market today
Netscientific raises up to £9.8mln as portfolio companies approach maturity
A placing and subscription at 45p will raise £8.1mln, while a further £1.5mln can come from a private placing
Archive
Proactive news round-up: Metal Tiger , Europa Oil & Gas, Falcon Media...
A glance at the small cap stories on the Proactive newswire today...
Trakm8 shares jump on roadside assistance technology company telematics contract win
A look at some of the biggest London-listed risers and fallers today
Netscientific business Vortex Bio kicks off lung cancer proof of concept trial
These studies are designed to provide proof of principle that biomarkers used for tumour biopsises can be adapted for circulating tumour cells (CTCs).
Archive
Proactive end of days news wrap: LGO Energy, Anglo Pacific, Caspian Sunrise...
A glance at the stories on the Proactive newswire today
Fruitflow dietary supplement group Provexis gets a boost
A look at some of the biggest London-listed risers and fallers today
NetScientific portfolio company ProAxsis secures second licensing deal for its ProteaseTag technology
“This agreement, which strengthens the company's intellectual property portfolio, puts ProAxsis in a great position to launch further immunoassays and point of care tests”
Footsie up ahead of close; unrest at ITV hits shares
The bulls could not quite push the top-share index above 7,400. Tomorrow they'll have a harder job with ex-div stocks lopping about 14 points off the Footsie
NetScientific: ProAxsis to present ProteaseTag data at ATS conference
The American Thoracic Society (ATS) conference takes place in Washington DC, between May 19 and May 24.
Archive
Proactive news round-up: Avacta Group, Galantas Gold, Aminex …
A glance at some of the stories on the Proactive newswire today
Motif Bio gains as Rodman & Renshaw hikes target price
A look at the top risers and fallers in London on Monday
NetScientific’s portfolio company nets “strong return” from sale of OncoVerse stake
Wanda has offloaded its holding in digital health platform OncoVerse to BTG plc for an undisclosed sum
FTSE 100 closes over 2% higher as France vote cheers
The FTSE 100 closed 150 points, or 2.11% higher, as investors welcomed Macron's result in the first round of France's presidential election
Archive
Proactive news round-up: AFC Energy, Telit Communications, Brave Bison ...
A glance at some of the stories on the Proactive newswire today
NetScientific to focus on enhancing value of portfolio this year
The board will continue to evaluate new pipeline opportunities but the focus in 2017 will be on growing what it has already got
NetScientific buoyed by Vortex’s tech endorsement
The firm commercialises intellectual property (IP) through developing early and mid-stage healthcare firms
Archive
Proactive news round-up: Hayward Tyler, Akers Biosciences, MaxCyte ...
A glance at some of the stories on the Proactive newswire today
Vortex technology further endorsed in recent papers, says NetScientific
As reported last month, the firm has begun the commercial launch of its VTX1 Liquid Biopsy System, which offers a breakthrough in early cancer detection.
Forbidden Technologies hit by chief exec resgination
Some the biggest rises and falls in London at 12 noon: Beowulf, Duet Real Estate, Servision
NetScientific hails commercial launch of breakthrough cancer detection device
The official launch took place in San Francisco at the Molecular Medicine Tri Conference.
Investments and investor services
FTSE 100 shares end higher as Unilever seeks more shareholder value
FTSE 100 shares ended higher on Wednesday, as Unilever talked up a review to show more shareholder value and Lloyds Banking posted its highest profit in a decade
Archive
Proactive news round-up: Falcon takes flight
Also featured: AFC, Ferrum Crescent, Galileo, Kibo, Lansdowne Oil, Metal Tiger, Netscientific, Powerhouse, REM, ReNeuron, Tern
NetScientific hails award-winning scientist
Vortex Biosciences' Elodie Sollier-Christen received the 2017 Society award for Laboratory Automation and Screening Innovation.
Archive
Proactive news round-up: Vast Resources, Arian Silver, NetScientific ...
A glance at some of the stories on the Proactive newswire today
NetScientific announces new CEO for portfolio company Wanda
Wanda uses machine learning in place of conventional technologies, thus enabling clinicians to make more informed care decisions
NetScientific provides more backing for cancer immunotherapies developer
The transatlantic healthcare IP commercialisation group has upped its stake in PDS Biotechnology
Proactive news summary: Windar Photonics has the wind behind it
Companies covered: ANGLE, Berkeley Energia, Best of the Best, Deltex, Forbidden Technologies, Frontier IP, Iofina, Ironridge, ITM Power, LGO Energy, Netscientific, Redx, ServicePower, Strategic MineralsPLC
NetScientific shares gain as Vortex makes commercialisation progress
Vortex updated on progress with its CTC capture system
Vortex Bio gains FDA registration for Class 1 medical device
Vortex Biosciences, a provider of circulating tumor cell (CTC) capture systems, Thursday announced it has registered a Class I medical device with the US Food and Drug Administration and established a CE Mark for its proprietary CTC capture
NetScientific's Vortex Biosciences has new director
Neff has served in a number of leadership positions in healthcare companies
Proactive news highlights: Highlands, Metal Tiger, MySQUAR, Seeing Machines and more...
Friday's headline round up from the Proactive news desk.
NetScientific celebrates CE mark breakthrough for its ProAxsis unit
"This is a very proud day for everyone at ProAxsis," said Dr David Ribeiro, CEO of ProAxsis
NetScientific revitalised by focus on core portfolio
The group has ambitions to strengthen its transatlantic focus through organic and strategic growth
Proactive News Highlights: Aminex, Amedeo Resources, Alliance Pharma, Constellation Healthcare and more...
A round up of the day's news from Proactive Investors.
NetScientific’s Wanda chosen by 24Hr HomeCare
24Hr HomeCare will use Wanda’s predictive analytics and behavioural guidance technology to help monitor the health of its patients
Risers & Fallers: Seeing Machines, Scotgold, GCM Resources ...
Significant share price risers and fallers in London at 4.15pm
NetScientific's Glycotest granted Japanese patent for liver disease test
The Japanese patent joins five others previously granted across Australia, US and Japan.
NetScientific’s Wanda appoints new non-exec
NetScientific’s portfolio company Wanda has appointed healthcare industry veteran Derek Newell to its board as non-executive director
Proactive news highlights: Bass Metals, Fox Marble, Netscientific and Stratmin Global
Fox Marble hit by currency fluctuations, Netscientific launches a phone app and Stratmin shareholders look forward to impending Graphmada sale.
App-y days as NetScientific’s portfolio company Wanda launches phone app
The app aims to empower women to improve the health of their hearts by offering support, education and guidance
Proactive news highlights: Forbidden Technologies, Netscientific, Rare Earth, StatPro and more...
Telit is collaborating with Indian information tech specialist, Vortex Biosciences granted licences for cell electroporation and Forbidden Technologies signs with a sports content group.
NetScientific investee company strikes Harvard licensing deal
Vortex Biosciences has been granted a series of licences for cell electroporation technology developed by Harvard researchers that will boost its ability to analyse circulation tumour cells (CTCs).
Proactive news highlights: ANGLE, Eckoh, Netscientific, Quartix, Savannah, W Resources and more...
W Resources kicks off its Spanish ambitions with a bang, ATTRAQT continues to see strong uptake and Eurasia Mining expects to produce the first concentrate from its West Kytlim alluvial platinum prospect.
Netscientific hails Wanda’s new medical director
Netscientific hailed the appointment of a renowned cardiologist as medical director at its portfolio firm Wanda.
NetScientific ‘totally revitalised’ under Francois Martelet, says chairman Sir Richard Sykes
“We now have a focused portfolio of assets which are close to commercialisation and which offer the scope for significant value creation,” Sykes said ahead of a Capital Markets Day.
Allergy Therapeutics appoints ex- Skyepharma man as FD
Peter Jensen, Allergy’s chairman said Wykeham’s experience in life sciences was well suited to Allergy.
NetScientific invests in PDS Biotech
NetScientific has ploughed a further US$500,000 in the immuno-oncology company after originally investing in PDS Biotechnology back in 2014.
Proactive news highlights: Amur Minerals, Beowulf Mining, Hurricane Energy, SolGold and more
Stratex is on course to hit targets, Beowulf thrown into disarray over Environmental report and Fastnet is to rename...
NetScientific portfolio company to present at prestigious cancer conference
Vortex will present data at the AACR that demonstrates the ability of its technology to rapidly collect highly enriched populations of circulating tumour cells
NetScientific buoyed by trial results; to spend further $500k
The phase I study looked at the method of action of the Versamune technology behind the treatment.
NetScientific PLC unveils Ian Postlethwaite as new CFO
We knew Postlethwaite was leaving Allergy Therapeutics after 14 years; now we know where he is going to
Week Ahead: Keywords Studios PLC going for new high score
The February trading update sent analysts scurrying to their calculators to upgrade their forecasts
NetScientific PLC's ProAxsis sets up scientific advisory board
The advisory board will support ProAxsis in the development of its Proteasetag activity-based immunoassays and point-of-care tests